| 中文名 | Deruxtecan analog |
|---|---|
| 英文名 | Deruxtecan analog |
| 中文别名 |
HER3抗体偶联体药物U3-1402
N-((S)-10-苄基-1-(((1S,9S)-9-乙基-5-氟-9-羟基-4-甲基-10,13-二氧代-2,3,9,10,13,15-六氢-1H,12H-苯并[DE]吡喃并[3',4':6,7]吲哚嗪并[1,2-B]喹啉-1-基)氨基)-1,6,9,12,15-五氧代-3-氧杂-5,8,11,14-四氮杂十六烷-16-基)-6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)己酰胺 伊班膦酸杂质32 N-[(S)-10-苄基-1-[[(1S,9S)-9-乙基-5-氟-9-羟基-4-甲基-10,13-二氧代-1,2,3,9,10,12,13,15-八氢苯并[DE]吡喃并[3',4':6,7]吲嗪并[1,2-B]喹啉-1-基]氨基]-1,6,9,12,15-五氧代-3-氧杂-5,8,11,14-四氮杂十六烷-16-基]-6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)己酰胺 |
| 英文别名 |
N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide,contains solvents
Ibandronate Impurity 32 Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl] MC-GGFG-Exetecan Deruxtecan analog Deruxtecan(DX-8951) Deruxtecan, 10 mM in DMSO N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]glycinamide Deruxtecan Drew Tikang Drug-Linker Conjugates for ADC,Inhibitor,inhibit,Deruxtecan N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide MC-GGFG-Exetecan 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-{[({[(1S)-1-[({[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,1.0,13.0,11.02,2]tetracosa-1,6,12,14,16,17,19-htaen-23-yl]cbamoyl}methoxy)methyl]cbamoyl}methyl)cbamoyl]-2-phenylethyl]cbamoyl}methyl)cbamoyl]methyl}hexanamide |
| 描述 | Deruxtecan analog 是连接桥与药物的偶联物,是抗体-药物偶联物 (ADC) 的一部分。详细信息请参考专利文献 WO2017002776A1 中的化合物 1。 |
|---|---|
| 相关类别 | |
| 靶点 |
Drug-linker conjugates for ADC[1] |
| 体外研究 | 抗体-药物偶联物选择性地和有效地向肿瘤组织递送抗癌剂,并且具有显着的抗肿瘤功效,具有广泛的治疗窗[2]。 |
| 参考文献 |
| 密度 | 1.48±0.1 g/cm3 |
|---|---|
| 沸点 | 1491.1±65.0 °C |
| 分子式 | C52H56FN9O13 |
| 分子量 | 1034.05 |
| 储存条件 | -20°C,密闭,干燥 |